Health2 days ago
Citigroup Raises Cytokinetics Price Target to $84 Amid Analyst Activity
Cytokinetics, Inc. (NASDAQ: CYTK) has received a price target increase from Citigroup, which raised its target from $77.00 to $84.00, as detailed in a research report...
